Psychiatry and Neurology, Neurology · Andalusia, AL
NPI
1760471817
Since 2005
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
2
Medicare group memberships
Hospitals
3
Hospital affiliations
947 S Three Notch St
Andalusia, AL, 36420
Phone (334) 222-3222
Groups this clinician bills Medicare through
Medicare paid, 2024
$368K
7,478 services
Medicare patients, 2024
523
Average age 72
Drug cost, 2024
$2.4M
11,600 prescriptions
Company payments, 2025
$1,469
From 21 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Sadik Yesil was code 99214 (office e&m - established), 1,109 times for 432 patients. In total Sadik Yesil billed 7,478 services in 22 codes, and Medicare paid $368K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-02-18.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 1,109 | 432 | $78.60 | $87K |
| 99213 Office E&M - Established | Office | 910 | 309 | $59.05 | $54K |
| 93886 Ultrasound - Nonspecific | Office | 288 | 282 | $184.79 | $53K |
| 93880 Duplex Scan - Extracranial Arteries | Office | 286 | 280 | $128.13 | $37K |
| 95885 Electrical Nerve Conductivity | Office | 271 | 110 | $41.39 | $11K |
| 95816 Neurologic | Office | 221 | 206 | $256.72 | $57K |
| 99204 Office E&M - New | Office | 138 | 138 | $112.25 | $15K |
| 95912 Electrical Nerve Conductivity | Office | 71 | 71 | $163.74 | $12K |
| 99205 Office E&M - New | Office | 53 | 53 | $138.35 | $7,333 |
| 95913 Electrical Nerve Conductivity | Office | 51 | 50 | $192.21 | $9,802 |
| 99215 Office E&M - Established | Office | 23 | 19 | $99.79 | $2,295 |
By year: 2022 $286K for 7,675 services; 2023 $369K for 7,101 services; 2024 $368K for 7,478 services.
Medicare prescription drug claims, 2024
In 2024, the drug Sadik Yesil prescribed most often to Medicare patients was Gabapentin, with 1,170 prescriptions and refills. In total Sadik Yesil wrote 11,600 Medicare prescriptions that cost $2.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Gabapentin Generic | 1,170 | 1,270 | 253 | $11K |
| Memantine Hcl Generic | 1,071 | 1,620 | 244 | $21K |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 837 | 837 | 101 | $18K |
| Clonazepam Generic | 777 | 782 | 125 | $4,699 |
| Butalbital-Acetaminophen-Caffe Butalb/Acetaminophen/Caffeine | 554 | 625 | 123 | $16K |
| Primidone Generic | 528 | 781 | 111 | $7,581 |
| Levetiracetam Generic | 439 | 693 | 93 | $7,750 |
| Tramadol Hcl Generic | 435 | 463 | 108 | $2,504 |
| Pregabalin Generic | 298 | 342 | 76 | $4,914 |
| Clopidogrel Clopidogrel Bisulfate | 272 | 558 | 76 | $2,274 |
| Meloxicam Generic | 263 | 360 | 70 | $1,252 |
| Donepezil Hcl Generic | 240 | 413 | 63 | $2,028 |
| Cyclobenzaprine Hcl Generic | 213 | 371 | 64 | $3,481 |
| Nurtec Odt Rimegepant Sulfate | 203 | 203 | 38 | $307K |
| Meclizine Hcl Generic | 200 | 281 | 58 | $4,947 |
Brand drugs: 738 claims; generic drugs: 10,833 claims; opioid claims: 1,443.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Sadik Yesil $1,469 ($1,469 in general payments such as food, travel and fees) from 21 companies. The largest payer was Pfizer Inc. with $342.
| Company | Payments | Amount |
|---|---|---|
| Pfizer Inc. PFE | 27 | $342 |
| UCB, Inc. UCB.BR | 6 | $147 |
| Abbvie Inc. ABBV | 7 | $143 |
| Argenx US, Inc. ARGX | 6 | $133 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 5 | $97.76 |
| Lundbeck LLC | 3 | $66.35 |
| Axsome Therapeutics, Inc. AXSM | 3 | $55.78 |
| Novartis Pharmaceuticals Corporation NVS | 3 | $55.39 |
| Amneal Pharmaceuticals LLC AMRX | 2 | $52.97 |
| Abbott Laboratories ABT | 3 | $51.07 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.